Atlanta I.D. Group ( Site 5680) — Atlanta, Georgia

Atlanta I.D. Group ( Site 5680) is a clinical research site located in Atlanta, Georgia, United States 30309.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Atlanta I.D. Group ( Site 5680) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HIV-1 Infection.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atlanta I.D. Group ( Site 5680)?

Atlanta I.D. Group ( Site 5680) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atlanta I.D. Group ( Site 5680) conducted?

Atlanta I.D. Group ( Site 5680) has 1 clinical trials on record, with 1 currently active. Their work covers HIV-1 Infection.

Is Atlanta I.D. Group ( Site 5680) accredited by Crixeo Clinical Trials?

Atlanta I.D. Group ( Site 5680) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atlanta I.D. Group ( Site 5680)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.